Sun Pharmaceutical Industries Ltd.

BSE: 524715 | NSE: SUNPHARMA
Large Cap | Pharmaceuticals & Drugs
1847.30
12.90 (0.70%)
< Home < Back

Sun Pharmaceutical Industries informs about press release

Date: 14-09-2023

Sun Pharmaceutical Industries has informed that it enclosed a Press Release relating to licensing agreement between Sun Pharma and Pharmazz Inc. for introducing Tyvalzi™ (Sovateltide) in India.

The above information is a part of company’s filings submitted to BSE.